
Over the last 7 days, the Healthcare Services industry has dropped 2.0%, driven by pullbacks in Excelsior Medical and Universal Vision Biotechnology of 2.9% and 3.1%, respectively. In contrast, Sofiva GenomicsLtd has gained 16%. The industry has fallen 18% in the last year. Looking forward, earnings are forecast to grow by 35% annually.
Has the Taiwanese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 09 Feb 2026 | NT$70.8b | NT$41.6b | NT$2.9b | 17.2x | 24.8x | 1.7x |
| Wed, 07 Jan 2026 | NT$74.0b | NT$41.6b | NT$2.9b | 17.2x | 25.9x | 1.8x |
| Fri, 05 Dec 2025 | NT$75.9b | NT$41.6b | NT$2.9b | 17.6x | 26.6x | 1.8x |
| Sun, 02 Nov 2025 | NT$73.4b | NT$41.7b | NT$2.8b | 19.2x | 26.2x | 1.8x |
| Tue, 30 Sep 2025 | NT$74.6b | NT$41.7b | NT$2.8b | 18.9x | 26.6x | 1.8x |
| Thu, 28 Aug 2025 | NT$75.4b | NT$41.9b | NT$2.8b | 18.5x | 26.7x | 1.8x |
| Sat, 26 Jul 2025 | NT$76.3b | NT$41.3b | NT$3.1b | 17.8x | 24.7x | 1.8x |
| Mon, 23 Jun 2025 | NT$74.2b | NT$41.3b | NT$3.1b | 18.4x | 24x | 1.8x |
| Wed, 21 May 2025 | NT$75.1b | NT$41.3b | NT$3.1b | 18.2x | 24.3x | 1.8x |
| Fri, 18 Apr 2025 | NT$78.5b | NT$41.2b | NT$2.7b | 17.7x | 29.4x | 1.9x |
| Sun, 16 Mar 2025 | NT$86.6b | NT$41.0b | NT$2.6b | 19.3x | 33.6x | 2.1x |
| Tue, 11 Feb 2025 | NT$87.5b | NT$41.2b | NT$2.7b | 21x | 32.5x | 2.1x |
| Thu, 09 Jan 2025 | NT$86.2b | NT$39.9b | NT$2.9b | 20.4x | 30.1x | 2.2x |
| Sat, 07 Dec 2024 | NT$88.8b | NT$39.9b | NT$2.9b | 19.6x | 31x | 2.2x |
| Mon, 04 Nov 2024 | NT$81.7b | NT$39.4b | NT$2.8b | 22.6x | 29.1x | 2.1x |
| Wed, 02 Oct 2024 | NT$86.8b | NT$39.4b | NT$2.8b | 23.1x | 30.9x | 2.2x |
| Fri, 30 Aug 2024 | NT$84.4b | NT$39.6b | NT$2.8b | 23.3x | 29.9x | 2.1x |
| Sun, 28 Jul 2024 | NT$86.7b | NT$38.9b | NT$2.8b | 21.7x | 31.2x | 2.2x |
| Tue, 25 Jun 2024 | NT$87.2b | NT$38.9b | NT$2.8b | 23.4x | 31.3x | 2.2x |
| Thu, 23 May 2024 | NT$86.2b | NT$39.0b | NT$2.8b | 20.2x | 31.2x | 2.2x |
| Sat, 20 Apr 2024 | NT$86.4b | NT$38.9b | NT$2.8b | 21.3x | 30.5x | 2.2x |
| Mon, 18 Mar 2024 | NT$87.8b | NT$38.8b | NT$3.0b | 22.9x | 29.7x | 2.3x |
| Wed, 14 Feb 2024 | NT$87.5b | NT$37.9b | NT$2.8b | 23.4x | 31.3x | 2.3x |
| Fri, 12 Jan 2024 | NT$86.6b | NT$37.1b | NT$2.8b | 23.1x | 31.4x | 2.3x |
| Sun, 10 Dec 2023 | NT$83.8b | NT$37.1b | NT$2.8b | 24x | 30.4x | 2.3x |
| Tue, 07 Nov 2023 | NT$85.4b | NT$37.0b | NT$2.9b | 24.4x | 29.4x | 2.3x |
| Thu, 05 Oct 2023 | NT$90.6b | NT$37.0b | NT$2.9b | 25.1x | 31.1x | 2.4x |
| Sat, 02 Sep 2023 | NT$90.4b | NT$37.0b | NT$2.9b | 24.4x | 31.1x | 2.4x |
| Mon, 31 Jul 2023 | NT$93.7b | NT$37.4b | NT$2.9b | 23.5x | 31.8x | 2.5x |
| Wed, 28 Jun 2023 | NT$95.8b | NT$37.3b | NT$3.0b | 24.6x | 32.5x | 2.6x |
| Fri, 26 May 2023 | NT$94.0b | NT$37.0b | NT$3.1b | 22.9x | 30.5x | 2.5x |
| Sun, 23 Apr 2023 | NT$90.0b | NT$36.9b | NT$3.1b | 19.2x | 29.2x | 2.4x |
| Tue, 21 Mar 2023 | NT$84.6b | NT$36.4b | NT$3.3b | 18.6x | 25.6x | 2.3x |
| Thu, 16 Feb 2023 | NT$79.5b | NT$36.5b | NT$3.3b | 18x | 24.1x | 2.2x |
24.1x
Which industries have driven the changes within the Taiwanese Healthcare industry?
| TW Market | -1.02% | |
| Healthcare | -1.61% | |
| Healthcare Services | -2.01% | |
| Healthcare Services | -1.68% | |
| Healthcare Distributors | -2.07% | |
| Healthcare Facilities | -3.93% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6879 TCI GENE | NT$38.15 | 7.0% +NT$66.1m | -26.6% | PE28.2x | |
| 6615 Sofiva GenomicsLtd | NT$33.95 | 5.8% +NT$39.9m | -18.2% | PS1.9x | |
| 6637 Medical Imaging | NT$76.90 | 0.8% +NT$16.1m | -12.6% | PE10.8x | |
| 3118 Level Biotechnology | NT$32.95 | 1.4% +NT$14.6m | 2.3% | PE13.2x | |
| 6518 Concord Medical | NT$26.05 | 0.6% +NT$5.0m | 0.4% | PE15.9x |